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ABSTRACT 
Leaves of Argemone mexicana L. (Papaveraceae) are used in the folk medicine of Burkina Faso (West Africa) 
to treat a variety of illness. Aqueous decoction of the drug is indicated in the treatment of malaria fever, 
abdominal pains, and jaundice. A preliminary study led by the authors showed a good anti-icterus 
(hepatoprotective) activity of leaves extracts on intoxicated Wistar rats. 
The aim of the present investigation was to evaluate the anti-icterus activity of crude leaf powder against CCl4 
induced hepatotoxicity in rats. Liver functions were assessed by the activities of liver marker enzymes, 
ASAT/GOT, ALAT/GPT, ALP, Total Bilirubin (TBIL) and Direct Bilirubin (DBIL).  
A crude powdered leaf suspended in acacia gum solution (2% p/w) was administered orally to the animal at 
doses of 125, 250 and 500 mg/kg attenuated significantly (p<0,05) the elevation of serum enzymes level and 
bilirubin (total and direct) if compared to the CCl4 treated groups. Silymarin (100 mg/kg, p.o.), a known anti-
hepatoprotective drug was used as reference.  
The results showed a dose-dependent anti-hepatotoxic effect against liver injury induced by CCl4 in rats. These 
findings give an opportunity for a future elaboration of galenic formulation as phytomedicament. 
Keywords: argemone mexicana, crude leaf powder, anti-icterus effect. 
INTRODUCTION 
In the absence of reliable liver protective drugs in modern medicine, it exists in the field of medicinal plants a 
great number of preparations recommended for the treatment of liver ailment. The use of medicinal preparations 
is in vogue since centuries and are quite often claimed to offer significant relief. An application of Argemone 
mexicana L. (Papaveraceae) crude leaf powder in traditional medicine in Burkina Faso is for the treatment of 
jaundice (icterus), particularly in the area of the “Cascades” region. Therefore, the anti-icterus activity of the 
powdered drug against CCl4-induced liver damages was investigated.  
Argemone mexicana L. (Papaveraceae), originated from Mexico, is a pan-tropical medicinal plant, which has a 
long history of use in traditional medicine dating back to the Aztecs (Emmart, 1940). It is a well-known plant 
used in certain regions of the world to treat several diseases: in India, the leaves decoction are indicated for 
treatment of bacterial pathology in the Ayurvedic medicine (Indranil et al., 2006). In West Africa, A. mexicana 
is used as uncomplicated malaria remedy in Mali (Willcox et al., 2007) and Burkina Faso (Sourabié et al., 2006, 
2009, 2010). 
Particularly in the case of Burkina Faso (statistics DGPML, 2006), it is estimated that more than 70% of people 
still rely on medicinal plants for the treatment of various diseases; and Argemone mexicana is specially used in 
the area of Cascades (south western part of Burkina Faso) for the treatment of malaria, fever and jaundice 
(icterus). According to the traditional medical practitioners in this area, the plant (A. mexicana) posses important 
pharmacological properties explaining its use as anti-inflammatory, analgesic antipyretic, antimicrobial and 
antispasmodic. 
On the chemical way, many authors reported that interesting secondary metabolites are present in the drug (Bose 
et al., 1963; Harbone and Williams, 1983; Upreti et al., 1991) such as glycosides, tannins, saponins and 
alkaloids, especially isoquinolein alkaloids type as sanguinarin, dihydrosanguinarin, berberin, protopin, etc.  
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hepatic injury in rats in order to give an explanation about utilization of that plant in the folk medicine of 
Burkina Faso. 
MATERIALS AND METHODS 
  Plant material 
Argemone mexicana leaves were collected in December 2004 in two villages (Beregadougou and Fabedougou), 
located about ten (10) to twelve (12) kilometers from Banfora (450 km from Ouagadougou, south western). A 
specimen sample of the drug, brought in Ouagadougou was firstly identified in the laboratory of Pharmacognosy 
(UFR/SDS, University of Ouagadougou). The identification of the specimen sample was also confirmed and 
certified by the botanical specimen preserved in the museum of Botany Department. The registration number of 
the specimen was HBNU 762 
  Preparation of the Crude leaf powder  
The leaves after drying in the shade and under ventilation were crushed in order to obtain crude powder. This 
crude powder was later tamised in fine powder (diameter of particles; 100µm). During the test moment, this fine 
powder serving as drug will be suspended in in acacia gum solution (2% p/w) before administration to the rats. 
  Experimental animals 
Male and female Wistar rats (200-230 g) were allotted into six groups of six animals each; they provided by the 
laboratory of CIRDES (360 km from Ouagadougou. Before the commencement of the experiments, the rats 
were acclimatized to laboratory conditions for one week. They were fed with standard rat feed and water ad 
libitum and kept in standard animal facility environment, temperature between 25 and 30°C, 12h light/12h dark 
(light cycle). 
  Drug and chemicals 
All the drug and chemicals used were of analytical grade. Silymarin was purchased from pharmaceutical officin; 
carbon tetrachloride was purchased by phytochemical laboratory; SGOT, SGPT, ALP and Direct Bilirubin 
(DBIL) were procured from Univers Biomedical Lab. 
  Acute toxicity test 
The test groups of rats (six groups of 5 rats each) received orally the fine crude leaf powder suspended in acacia 
gum solution (2% p/w). Several doses of drug corresponding to each group were used: 250, 500, 1000, 2000 and 
2500 mg/kg p.o. Control group received only the vehicle (2% w/v aqueous gum acacia) at the dose of 5 mL/kg. 
After administration, all treated rats were kept for observation in order to detect signs of toxicity and mortality 
during 24h, 48h, 72h and beyond. 
  Animal treatment (anti-icterus test) 
The study of anti-icterus (hepatoprotective) properties due to the medicinal plants is characterized by a great 
variety of protocols (Fleurentin J., 1990). So for the present work, we adopted the method of Rao and Mishra 
(1998), Al-Qarawi et al., (2003), which methods were appropriated to our laboratory context. For the 
experience, the rats were divided into six groups of six (06) animals each (n= 6 per group). Group I served as 
normal control and then received the vehicle (5mL/kg p.o.) during nine (09) days; Group II served as positive 
control intoxicated (CCl4), received equally every day the vehicle (0,5mL/kg, i.p.); Group III served as standard, 
(silymarin is given at a dose of 100 mg/kg); groups IV, V and VI received drug treatment corresponding 
respectively to the doses of 125, 250 and 500 mg/kg per os. 
At the seventh day, the animals of all groups, excepted those of group I received carbon tetrachloride CCl4 (0,5 
mL/kg, i.p.). At the end of experimental period corresponding to the tenth day, the rats were sacrificed after 
ether anesthesia. Blood samples were collected by direct cardiac puncture and kept in EDTA containing vials for 
10 minutes, then it is centrifuged for 5-10 minutes at 2500 rpm. 
The serum was collected and used for biochemical estimations like aspartate aminotransferase (AST/GOT), 
alanine aminotransferase (ALT/GPT), phosphatase alkaline (ALP), total bilirubin (TBIL) and direct bilirubin 
(DBIL) as per standard procedures, mainly those of Mukherjee et al., (2002); Henry R.J., (1974), Enrique E. and 
Slivo R., (1926). Dosage of biochemical markers was done by an automate type Konelab 20. This instrument 
uses only specific reagents. 
The results were expressed as percent hepatoprotective (anti-icteric) according to the formula of Al-Qarawi et 
al., (2003). The percentage reduction of the hepatotoxin (CCl4) was calculated considering the enzyme level 
difference between the hepatotoxin-treated and the control group as 100% level of reduction  
  Statistical Analysis 
Results were presented as mean ± SEM for all values; One way ANOVA was used to statistically analyzed the 
results followed by Student “t’’ test. The level of significance if kept at P<0,05. 
T.S. Sourabie et al. / International Journal of Pharma Sciences and Research (IJPSR)
ISSN : 0975-9492 Vol 3 No 10 Oct 2012  492RESULTS AND DISCUSSION 
  Results 
Phytochemical screening about crude powder leaf of Argemone mexicana L. showed in majority the same 
chemical principles as those revealed in the study of Sourabié (2009) and equally by Léga (2010). These 
chemical principles identified are summarized in table 1. Concerning the acute toxicity test, the suspension of 
the leaf powder did not show any mortality even at the dose of 2500 mg/kg b.wt (Sourabié et al., 2009). 
The effect of crude powdered leaf of Argemone mexicana L. on serum transaminases (GOT/AST; GPT/ALT), 
alkaline phosphatase (ALP), total bilirubin (TBil), and direct bilirubin (DBil) on CCl4-intoxicated rats are 
summarized in table 2. There was significant (p<0,01) increase in serum GOT (AST), GPT (ALT) and ALP 
levels in CCl4-intoxicated group (group II) if compared to the normal control group (group I). 
The effect of crude powdered leaf (Argemone mexicana) on total bilirubin (TBil) and direct bilirubin (DBil) are 
equally shown in table 2. For the two parameters, there was significant (p<0,05) elevation of total bilirubin and 
direct bilirubin in the serum of CCl4 intoxicated groups (group II) when compared to normal control group 
(group I). The crude leaf powder (suspension) in the different doses (125, 250 and 500 mg/kg b.wt) reduced the 
levels of total and direct bilirubin (table 2). 
  Pharmacological profile of the anti-icterus effect 
In order to define how the anti-icterus effect is exhibited, we have determined the “hepatoprotective power” 
(HP) of the drug from the five (05) investigated biochemical parameters. This has been done in order to know if 
the anti-icterus effect is dose-dependent or not. The hepatoprotective power (H.P.) is calculated according to the 
following formula: 
H.P.(%) = percent reduction of [GOT+GPT+ALP+TBIL+DBIL]/5 
where H.P.= hepatoprotective power”of the drug at the dose considered, expressed in mean percentage (%) of 
reduction. 
GOT: glutamic oxalacetic transaminase; GPT: glutamic pyruvic transaminase; ALP: alkaline phosphatase 
TBIL: total bilirubin; DBIL: direct bilirubin 
[GOT+GPT+ALP+TBIL+DBIL] = the amount of reduction percentage of the 5 investigated biochemical 
parameters. 
The results of Hepatoprotective Power (HP), compared to that of silymarin showed a dose-dependent anti-
icterus profile about the crude powdered leaf of Argemone mexicana Linn. (table 2,). 
Results presented in table 3 showed effectively presence of anti-icterus effect exerted by the leaf powder. The 
pharmacological action is present on all the biochemical parameters studied. If compared with silymarin (100 
mg/kg), the Hepatoprotective Power of the crude powdered leaf of Argemone mexicana Linn. is increased when 
the dose administered to the rats becomes more and more higher. These results confirm the dose-dependent 
property that characterizes the crude powdered leaf of Argemone mexicana Linn. 
  Discussion 
Protection against CCl4-induced liver injury has been taken as a test for potential anti-hepatotoxic 
(hepatoprotective) agent by several investigators (Sha et al., 2009; Sanmugapriya (2006). Furthermore the 
changes associated with CCl4-induced liver damage are similar to that of acute viral hepatitis (Suja et al., 2004); 
so CCl4-mediated hepatotoxicity was chosen as the experimental model. 
Moreover, the ability of a hepatoprotective drug (as the crude powdered leaf of Argemone mexicana L.) to 
reduce the injurious effects or to preserve the normal hepatic physiological mechanism, that have been disturbed 
by a hepatotoxin (CCl4; 0,5 mL/kg i.p.), is the index of its protective effect according to Yudav and Dixit 
(2003). 
In the present work, the increase of the levels of serum markers GOT, GPT, ALP and Bilirubin (total and direct) 
are the signs which showed significant hepatic damage in CCl4 intoxicated rats (group II) as shown in table 2. 
This hepatic injury can be attributed to the structural integrity damage of liver, because these enzymes have a 
cytoplasmic location and released into circulation after cellular damages, indicating development of 
hepatotoxicity according to Sallie et al., (1991). Carbon tetrachloride (CCl4) is the main responsible of that 
toxicity which causes multiple damages in the liver. Its toxicity is due to the metabolites particularly the 
trichloromethyl (.CCl3) and the derivative trichloromethylperoxyde. These two metabolites are generated by the 
intermediate of cytochrome P450 hepatic oxidase.  
Thus, these free radicals can alkylate cellular proteins and other macromolecules with a simultaneous attack on 
polyunsaturated fatty acids in the presence of oxygen, to provide lipids peroxides, leading to liver damage 
(Sarada et al., 2012; Sanmugapriya et al., 2006; Bishayee et al. 1995). Hepatocellular necrosis leads to elevation 
of the biochemical serum enzymes levels, which are released from the liver into blood (Ashok et al., 2002). 
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indicators of liver injury according to Achliya et al., (2004). 
The results of our study revealed a significant increase of the activities of GOT, GPT, ALP and serum bilirubin 
levels on exposure to CCl4, indicating considerable hepatocellular damage. On the other hand, oral 
administration of crude powdered leaf to the intoxicated rats attenuated the increased levels of the serum 
enzymes, produced by CCl4 and caused a subsequent recovery towards normalization like that of silymarin 
treatment. 
This normalization of serum biochemical markers by crude powdered leaf of A. mexicana suggests that it is able 
to condition the hepatocytes so as to protect the membrane integrity against CCl4-induced leakage of 
biochemical marker enzymes into the blood plasma. We can affirm with great certitude that the above changes 
can be considered as an expression of the functional improvement of hepatocytes. 
Concerning the mechanism of action of the anti-hepatotoxic effect exhibited by the crude powdered leaf of 
Argemone mexicana, it can be attributed to the phytochemical components highlighted in the powdered 
suspension extracts. Effectively, according to Rathi et al. (2008) protopin, one of the isoquinoleic alkaloids of A. 
mexicana exerts an inhibition action on lipid peroxides formation. And it has been known that lipid peroxidation 
is one of the important steps of CCl4 metabolisation leading to the degradation of hepatocytes cells membranes. 
The mechanism of the anti-icterus effect can also be due to some phytoconstituents as sugars and glycosides 
present in the drug (Table 1). These components according to Chiu et al., (1992) and Ye et al., (2001) derived 
from polysaccharides that some of them have been well documented in literature about their anti-hepatotoxic 
property. 
The inhibition of lipid peroxidation by protopin creates a good condition for liver protection against CCl4-
intoxication that is known to cause many important damages to the liver. Finally, the mechanism of action 
exerted by protopin (isoquinoleic alkaloïd of A. mexicana) is similar to that of silymarin, considered as an 
inhibitor of cytochrome P450 (Sarada K. et al., 2012). The inhibitory role of silymarin was effectively confirmed 
by Letteron P. et al., (1990) concerning the metabolism of Carbon tetrachloride (CCl4). 
Silymarin inhibits the hepatic oxidase CYP450 (Cytochrome P450), the main enzyme responsible for the activation 
of carbon tetrachloride (CCl4) transformation into its metabolites notably radical trichloromethyl which leads to 
trichloromethylperoxyde, free radical. This derivative free radical (trichloromethylperoxyde) plays a great role 
in the lipids peroxidation leading to liver damage. 
The present work is of a great interest by the results obtained; in fact, the anti-icterus effect revealed by the leaf 
powder is similar to those shown by leaves extracts (Sourabié et al., 2012). And chemically, the 
phytoconstituents revealed in the crude powder leaf are practically the same discovered in the lyophilized 
extracts; this means that it is possible to administrate directly the powdered form of the drug to the patients. 
Another interest provided by these results is that the traditional medical practitioner can propose the powdered 
form of the drug for the treatment of their patients. By this way, the decoction step is avoided and this 
constitutes an advantage on therapeutic way. 
Finally for the researchers in the domain of medicinal plants, these findings provide a good opportunity to apply 
the results of fundamental research into applied one. In the case of the crude powdered leaf of A. mexicana 
Linn., it is possible to make a galenic formulation of the drug powder in order to elaborate a Traditional 
Ameliorated Medicament (TAM) called also Phytomedicament. The presentation in capsule form of this 
phytomedicine can follow the same procedure of formulation as FACA capsules, a phytomedicine produced by 
the Research Institut of Health Service (IRSS) and which is used in the treatment of acute crisis of sickly cell 
disease (drepanocytosis). 
CONCLUSION 
The results of the present work showed the anti-icterus (anti-hepatotoxic) effect of crude powdered leaf of 
Argemone mexicana L. (Papaverceae) in dose-dependent manner similar to those of lyophilized extracts of the 
same drug. These results are very interesting since they constitute a good example for applied research by the 
elaboration of phytomedicine available for the treatment of icterus disease. Finally, our study gave a scientific 
basis to the traditional use of different parts of Argemone mexicana Linn. in Burkina folk medicine. 
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Table 1: Phytochemical compounds of Argemone mexicana L. leaf powder suspension; (In study of Sourabié et al. (2009)). 
 
 
 
                                               PHYTOCONSTITUENTS                                               
                  ___________________________________________________________ 
Drug yield (%)      AK               Flav                 Cg                St                  Pc                   
 
Leaf powder 
 
5,13 
 
++++ 
 
+ 
 
++ 
 
+ 
 
++ 
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+++= abundant, ++ = present; + = slightly present 
Tableau 2: effects of Argemone mexicana crude leaf powder on various biochemical parameters in rats with carbon  
tetrachloride induced hepatotoxicity. 
                                                                                            BIOCHEMICAL PARAMETERS                                        
               ------------------------------------------------------------------------------------------------------------------------------------------
--------------- 
   Grps          Doses (mg/kg)          GOT (UI/L)               GPT (UI/L)              ALP (UI/L)               TBil (mg/dL)          
DBil (mg/dL) 
I 
II 
III 
 
IV 
 
V 
 
VI 
 
-- 
-- 
100 
 
125 
 
250 
 
500 
65,6±2,68 
148,19±2,99** 
80,10±0,88 
(83,42%) 
96,37±1,11 
(62,74%) 
87,60±1,01 
(73,36%) 
78,84±0,90 
(83,96%) 
98,7±2,56 
119,37±1,06 
119,37±1,06 
(81,79%) 
145,10±1,05 
(81,79%) 
131,91±0,96 
(70,73%) 
118,72±0,86 
(82,37%) 
131,2±3,02 
219,80±2,29* 
149,15±1,30 
(79,74%) 
145,26±1,33 
(84,13%) 
142,06±1,21 
(87,74%) 
137,20±1,08 
(93,22%) 
1,57±0,06 
2,58±0,07* 
1,84±0,05 
(73,26%) 
1,90±0,09 
(67,32%) 
1,81±0,08 
(76,23%) 
1,58±0,09 
(82,17%) 
1,50±0,06 
2,46±0,07 
1,76±0,05 
(72,91%) 
1,79±0,09 
(69,79%) 
1,73±0,09 
(76,04%) 
1,69±0,08 
(80,20%) 
Values are mean ± S.E.; n = 6, values within parentheses represent percent hepatoprotection; *p<0,05; ** 
p<0,01 . Compared with normal control vs liver injured rats. 
Table 3: Dose-dependent anti-icterus profile of crude powdered leaf of A. mexicana L. (Papaveraceae) on CCl4-intoxicated rats. 
Silymarin*: 100 mg/kg p.o.  HP*: Hepatoprotective Power 
 
 
 
                                                               Doses/crude powdered leaf (mg/kg)     
                                                 ______________________________________________ 
                Silymarin*                  125 mg/kg                       250 mg/kg           500 mg/kg 
 
H.P.*(%) 
 
78,22% 
 
73,15% 
 
76,81% 
 
84,38% 
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